Ronit
Ronit Arginteanu, Cresskill, NJ US
Patent application number | Description | Published |
---|---|---|
20140193346 | HEALTH SUPPLEMENT - Herbal composition and method for the treatment of inflammatory pain associated with tendonitis, bursitis, arthritis, carpal tunnel syndrome, tennis elbow, plantar fasciitis, sports injuries, lower back pain and overexertion, gingivitis and muscle aches, that is compliant with HPUS monographs and/or over-the-counter FDA topical analgesic monograph requirements. | 07-10-2014 |
Ronit Elhasid, Tel-Aviv IL
Patent application number | Description | Published |
---|---|---|
20120107821 | METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF LEUKEMIA AND OTHER CANCER TYPES - Methods for diagnosing leukemia and other cancer types, so that the malignancy thereof dependent on expression of ARTS at low levels or an absence of ARTS expression are disclosed. Moreover methods for prognosis of leukemia and other cancer types, which are prone for an effective treatment by restoring ARTS expression levels and/or restoring cellular ARTS activity are further disclosed. | 05-03-2012 |
Ronit Ephrat, Tel-Aviv IL
Patent application number | Description | Published |
---|---|---|
20080313090 | Interaction-management methods and platform for client-agent interaction-related environments - A platform for enabling collaboration of components of a distributed interaction-related loosely-coupled system, and a method thereof are provided. The platform includes a communication medium and interaction-related business services capable of communicating via the communication medium using an interaction management protocol. The platform further includes one or more business process management services to create one or more business flows that utilize one or more of said business services | 12-18-2008 |
20110307258 | REAL-TIME APPLICATION OF INTERACTION ANLYTICS - A method and apparatus for providing real-time assistance related to an interaction associated with a contact center, comprising steps or components for: receiving at least a part of an audio signal of an interaction captured by a capturing device associated with an organization, and metadata information associated with the interaction; performing audio analysis of the at least part of the audio signal, while the interaction is still in progress to obtain audio information; categorizing at least a part of the metadata information and the audio information, to determine a category associated with the interaction, while the interaction is still in progress to obtain audio information; and taking an action associated with the category. | 12-15-2011 |
20120020473 | METHOD AND SYSTEM FOR ROUTING TEXT BASED INTERACTIONS - Embodiments of the invention are directed to a system and method for routing interactions. A method may include receiving a message related to the interaction. Text included in the message may be analyzed. A destination may be selected for the message based on analysis of the text. The message may be routed to the selected destination. | 01-26-2012 |
20120296642 | METHOD AND APPRATUS FOR TEMPORAL SPEECH SCORING - A method and apparatus for speech analysis, comprising detecting an at least one temporal characteristic of an at least one speech of an at least one speaker, and deducing an at least one quantitative score from the at least one temporal characteristic, where the at least one quantitative score indicates an at least one extent of an at least one behavioral aspect of the at least one speaker. | 11-22-2012 |
Ronit Haimov-Kochman, Mevasseret Zion IL
Patent application number | Description | Published |
---|---|---|
20080233583 | BIOMARKERS FOR PREECLAMPSIA - The present invention provides methods for predicting the development of and diagnosing preeclampsia, providing a prognosis, and predicting recurrence of the disease using molecular markers that are overexpressed or underexpressed in preeclampia. Also provided are methods to identify compounds that are useful for the treatment or prevention of preeclampsia. | 09-25-2008 |
Ronit Izhar, Ramat-Gan IL
Patent application number | Description | Published |
---|---|---|
20140006075 | Assigning a Consultant to an Enterprise System | 01-02-2014 |
Ronit Langzam-Sinai, Kiryat Tivon IL
Patent application number | Description | Published |
---|---|---|
20120078293 | APPLICATORS FOR PATCHES AND ADHESIVES - Apparatus is provided for use with a tubular structure ( | 03-29-2012 |
Ronit Nossenson, Kfar-Sava IL
Patent application number | Description | Published |
---|---|---|
20110002240 | SYSTEM AND METHOD FOR CREATING A TRANSITIVE OPTIMZED FLOW PATH - Traffic paths based on common devices available in a network are optimized, controlled, manipulated and created. The new paths used to optimize are not limited to the original OSI layer and/or original networks. Thus, various kinds of users/computers/devices, working in the same or in different abstraction layer networks, are combined into one collective virtual network providing the ability to compute and utilize the best (optimal) traffic path for each flow at each given time. The traffic path can be constructed especially for each flow. All or most devices and layer networks are combined in a collective virtual network when computing and constructing an optimized path for a flow. Thus, there is no need to add additional headers to a flow thereby eliminating the addition of overhead to the flow. | 01-06-2011 |
20110058549 | METHOD AND SYSTEM FOR LAYER 2 MANIPULATOR AND FORWARDER - The disclosure describes method and system for forwarding frames of a flow via a layer 2 forwarder and manipulator (L2FM) for improving network utilization and improving users experience by reducing the latency associated with the flow. When a new flow is identified, forward control information for frames of the new flow is obtained. The forward control information can include re-writing of at least one field in an original header of the frames of the new flow. At least one field in an original header of the frames of the new flow is manipulated according to the obtained forward control information, and the manipulated frames of the new flow are forwarded accordingly. | 03-10-2011 |
Ronit Popovitz-Biro, Revohot IL
Patent application number | Description | Published |
---|---|---|
20100172823 | PROCESS AND APPARATUS FOR PRODUCING INORGANIC FULLERENE-LIKE NANOPARTICLES - The present invention provides a process for obtaining fullerene-like metal chalcogenide nanoparticles, comprising feeding a metal precursor selected from metal halide, metal carbonyl, organo-metallic compound and metal oxyhalide vapor into a reaction chamber towards a reaction zone to interact with a flow of at least one chalcogen material in gas phase, the temperature conditions in said reaction zone being such to enable the formation of the fullerene-like metal chalcogenide nanoparticles product. The present invention further provides novel IF metal chalcogenides nanoparticles with spherical shape and optionally having a very small or no hollow core exhibiting excellent tribological behaviour. The present invention further provides an apparatus for preparing various IF nanostructures. | 07-08-2010 |
Ronit Popovitz-Biro, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20140287264 | ORDERED STACKED SHEETS OF LAYERED INORGANIC COMPOUNDS, NANOSTRUCTURES COMPRISING THEM, PROCESSES FOR THEIR PREPARATION AND USES THEREOF - Provided is a nanostructure including ordered stacked sheets and processes for its preparation and use. | 09-25-2014 |
Ronit Sarid, Or-Yehuda IL
Patent application number | Description | Published |
---|---|---|
20120027809 | Pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles and uses thereof - The present invention provides pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles, more particularly, pharmaceutical compositions comprising water-soluble sulfonate-protected silver or gold nanoparticles. The pharmaceutical compositions of the invention are useful in prevention or treatment of infections or conditions or disorders caused by microorganisms capable of binding to heparan sulfate, e.g., herpes simplex viruses. | 02-02-2012 |
Ronit Satchi-Fainaro, Tel-Aviv IL
Patent application number | Description | Published |
---|---|---|
20110085979 | CONJUGATE OF A POLYMER, AN ANTI-ANGIOGENESIS AGENT AND A TARGETING MOIETY, AND USES THEREOF IN THE TREATMENT OF BONE RELATED ANGIOGENESIS CONDITIONS - Conjugates of hydroxypropyl methacrylamide (HPMA)-derived copolymers having attached thereto TNP-470 and a high load (e.g., higher than 3 mol %) of alendronate (ALN), and processes of preparing same are disclosed. | 04-14-2011 |
20110142764 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES - Conjugates of polymers or copolymers having attached thereto an anti-angiogenesis agent and a bisphosphonate bone targeting agent, and processes of preparing same, are disclosed. | 06-16-2011 |
20110286923 | NOVEL CONJUGATES OF POLYMERS HAVING A THERAPEUTICALLY ACTIVE AGENT AND AN ANGIOGENESIS TARGETING MOIETY ATTACHED THERETO AND USES THEREOF IN THE TREATMENT OF ANGIOGENESIS RELATED DISEASES - Conjugates of a polymer having attached thereto an angiogenesis targeting moiety and a therapeutically active agent such as an anti-cancer agent or anti-angiogenesis agent, and processes of preparing same are disclosed. | 11-24-2011 |
20140010763 | ACTIVATABLE FLUOROGENIC COMPOUNDS AND USES THEREOF AS NEAR INFRARED PROBES - Novel fluorogenic compounds designed such that upon a chemical event, compounds capable of emitting NIR light are generated, are disclosed. The compounds comprise two or more acceptor-containing moieties and a cleavable donor-containing moiety, being in complete pi-electrons conjugation and being such that no delocalization of pi-electrons is enabled. Also disclosed are fluorescent compounds generated upon subjecting the fluorogenic compounds to a chemical event (e.g., deprotonation). Also disclosed are uses of the fluorogenic compounds as NIR probed with a Turn-ON mechanism in monitoring presence and/or level of various analytes. | 01-09-2014 |
20140079638 | NOVEL CONJUGATES OF POLYMERS HAVING A THERAPEUTICALLY ACTIVE AGENT AND AN ANGIOGENESIS TARGETING MOIETY ATTACHED THERETO AND USES THEREOF IN THE TREATMENT OF ANGIOGENESIS RELATED DISEASES - Conjugates of a polymer having attached thereto an angiogenesis targeting moiety and a therapeutically active agent such as an anti-cancer agent or anti-angiogenesis agent, and processes of preparing same are disclosed. | 03-20-2014 |
20140134111 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES - Conjugates of polymers or copolymers having attached thereto an anti-angiogenesis agent and a bisphosphonate bone targeting agent, and processes of preparing same, are disclosed. | 05-15-2014 |
20140212357 | CONJUGATE OF A POLYMER, AN ANTI-ANGIOGENESIS AGENT AND A TARGETING MOIETY, AND USES THEREOF IN THE TREATMENT OF BONE RELATED ANGIOGENESIS CONDITIONS - Conjugates of hydroxypropyl methacrylamide (HPMA)-derived copolymers having attached thereto TNP-470 and a high load (e.g., higher than 3 mol %) of alendronate (ALN), and processes of preparing same are disclosed. | 07-31-2014 |
20140271483 | TARGETED POLYMERIC CONJUGATES AND USES THEREOF - Polymeric conjugates comprising a polymeric backbone having attached thereto a bone targeting moiety and a therapeutically active agent, wherein the bone targeting moiety is attached to one end of the polymeric backbone via a branching unit such that a molar ratio of the bone targeting moiety to the polymer is at least 2:1, are disclosed. Pharmaceutical compositions containing these conjugates and uses thereof in the treatment of bone related disorders are also disclosed. | 09-18-2014 |
20150017115 | POLYMERS HAVING THERAPEUTICALLY ACTIVE AGENTS CONJUGATED THERETO, PROCESSES OF PREPARING SAME AND USES THEREOF - Polymeric conjugates of a polymeric backbone formed of a plurality of backbone units and having attached to portions of the backbone units two or more therapeutically active agents, or one or more therapeutically active agents and a NCAM targeting moiety, are disclosed. Uses of such polymeric conjugates in treating and/or monitoring cancer and/or medical conditions associated with angiogenesis are also disclosed. | 01-15-2015 |
Ronit Satchi-Fainaro, Chestnut Hill, MA US
Patent application number | Description | Published |
---|---|---|
20080248030 | Method of Treating Angiogenic Diseases - The present invention relates to methods for treating cancer comprising administering an anti-VEGF (vascular endothelial growth factor) monoclonal antibody (e.g. Avastin) and a N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-TNP-470 conjugate (e.g. Caplostatin) to a patient in need thereof. | 10-09-2008 |
20090176874 | TNP-470 POLYMER CONJUGATES AND USE THEREOF - The present invention relates to conjugates of water-soluble polymers and o-(chloracetyl-carbamoyl) fumagillol (TNP-470) and use of those conjugates as specific intracellular carriers of the TNP-470 into tumor vessels. The present invention further relates to use of those conjugates to lower the neurotoxicity of TNP-470. Preferably, the polymer has a molecular weight in the range of 100 Da to 800 kDa. More preferably, the polymer has a molecular weight no greater than 60 kDa. Most preferably, the polymer has a molecular weight in the range of 15 kDa to 40 kDa. | 07-09-2009 |
Ronit Shaltiel-Karyo, Ramat-Hasharon IL
Patent application number | Description | Published |
---|---|---|
20110319334 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES - Isolated peptides are provided, being less than 20 amino acids in length. The peptides comprising an amino acid sequence GVLYVGSKTREGV (SEQ ID NO: 12) AAATGLVKREE (SEQ ID NO: 13) or GVVAAAEKTKQG (SEQ ID NO: 14), mimetics and/or fragment thereof, the peptides being capable of inhibiting alpha synuclein aggregation. Pharmaceutical compositions comprising same are also provided as well as uses thereof. | 12-29-2011 |
20130244946 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES - Isolated peptides are provided, being less than 20 amino acids in length. The peptides comprising an amino acid sequence GVLYVGSKTREGV (SEQ ID NO: 12) AAATGLVKREE (SEQ ID NO: 13) or GVVAAAEKTKQG (SEQ ID NO: 14), mimetics and/or fragment thereof, the peptides being capable of inhibiting alpha synuclein aggregation. Pharmaceutical compositions comprising same are also provided as well as uses thereof. | 09-19-2013 |
Ronit Sharabi, Kfar Yona IL
Patent application number | Description | Published |
---|---|---|
20150263386 | LITHIUM ION SECONDARY BATTERY COMPRISING A SILICON ANODE - A lithium ion secondary battery comprising: (i) a cathode comprising a cathode active material that can reversibly oclude and release lithium ions wherein the upper cut-off voltage for the cathode during charging against Li/Li | 09-17-2015 |
Ronit Shtrichman, Haifa IL
Patent application number | Description | Published |
---|---|---|
20130130387 | METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS FROM KERATINOCYTES DERIVED FROM PLUCKED HAIR FOLLICLES - A method for generating induced pluripotent stem (iPS) cells from isolated hair follicles is disclosed. The method comprises: | 05-23-2013 |
20130230601 | ISOLATED MESENCHYMAL PROGENITOR CELLS AND EXTRACELLULAR MATRIX PRODUCED THEREBY - Provided are methods of isolating an extracellular matrix from mesenchymal progenitor cells which are characterized by a reduced differentiation ability into an adipogenic lineage as compared to adipose-derived mesenchymal stem cells. Also provide isolated extracellular matrix and hybrid devices comprising electrospun elements and extracellular matrix which can be used for various tissue regeneration, repair and reconstruction surgeries. | 09-05-2013 |
Ronit Simantov, New Haven, CT US
Patent application number | Description | Published |
---|---|---|
20130058948 | Antibodies Directed To Gpnmb And Uses Thereof - The present invention provides fully human monoclonal antibodies that specifically bind to GPNMB, and uses thereof. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs) are provided. The present invention also provides immunoconjugates comprising anti-GPNMB antibodies and methods of using such immunoconjugates. The present invention further provides methods of treating breast cancer using antibodies that bind to GPNMB, immunoconjugates and other derivatives thereof. | 03-07-2013 |
Ronit Simhony, Binyamina IL
Patent application number | Description | Published |
---|---|---|
20120095127 | Artificial marble and methods - There is provided an artificial marble that includes antimicrobial substance, wherein the antimicrobial substance comprises less that about 0.002% (dry weight) of the artificial marble composition. | 04-19-2012 |
Ronit Slyper, Pittsburgh, PA US
Patent application number | Description | Published |
---|---|---|
20100309209 | System and method for database driven action capture - There is provided a system and method for database driven action capture. By utilizing low cost, lightweight MEMS devices such as accelerometers, a user friendly, wearable, and cost effective system for motion capture is provided, which relies on a motion database of previously recorded motions to reconstruct the actions of a user. By relying on the motion database, calculation errors such as integration drift are avoided and the need for complex and expensive positional compensation hardware is avoided. The accelerometers may be implemented in an E-textile embodiment using inexpensive off-the-shelf components. In some embodiments, compression techniques may be used to accelerate linear best match searching against the motion database. Adjacent selected motions may also be blended together for improved reconstruction results and visual rendering quality. Various perceivable effects may be triggered in response to the reconstructed motion, such as animating a 3D avatar, playing sounds, or operating a motor. | 12-09-2010 |
20110177753 | SYSTEM AND METHOD FOR GENERATING REALISTIC EYES - Realistic electronically controlled eyes for a figure such as a doll, toy, animatronic being, robot, etc., are provided by displaying a sequence of images simulating eye movement on an electronic display screen mounted to a portion of the figure. A convex lens, which serves to simulate the figure's eye, is mounted substantially in contact with a surface of the display screen system from which the light defining the sequence of images is emitted. To an observer looking at the convex surface of the lens, the lens appears as an eye characterized by realistic eye movement. | 07-21-2011 |
Ronit Yahalomi, Kiryat Bialik IL
Patent application number | Description | Published |
---|---|---|
20080319075 | Polymorphic forms of nateglinide - Provides are crystalline forms of nateglinide, labeled Forms A, C, D, F, G, I, J, K, L, M, N, O, P, Q, T, U, V, Y, α, β, γ, δ, ε, σ, θ and Ω, processes for their preparation and processes for preparation of other crystalline forms of nateglinide. Also provided are their pharmaceutical formulations and methods of administration. | 12-25-2008 |
Ronit Yarden, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20140323563 | USE OF STRIGOLACTONES AND STRIGOLACTONE ANALOGS FOR TREATING PROLIFERATIVE CONDITIONS - Compound of formula X wherein P | 10-30-2014 |
Ronit Zvitov, Rishon Lezion IL
Patent application number | Description | Published |
---|---|---|
20100015227 | DRIED ELECTRIFIED HYDROCOLLOID GELS HAVING UNIQUE STRUCTURE AND POROSITY - This invention discloses electrified freeze-dried hydrocolloid gels, having modified structures with improved properties, as well as methods for the preparation of these modified gels and their uses. Specifically gels modified by electrification and freeze-drying undergo changes including creation of concentric layers of gel and intervening spaces. | 01-21-2010 |